Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PFI financials

This article was originally published in The Tan Sheet

Executive Summary

Pharmaceutical Formulations first quarter net sales reached $18.4 mil., a 13.2% increase over the comparable period last year, attributable to the addition of sales from Konsyl Pharmaceuticals, acquired roughly one year ago. Excluding Konsyl, sales fell 2.2% to $15.9 mil., reflecting "increased price competition in the private label over-the-counter market, higher retailer rebate programs and an abrupt decline in the overall cough/cold market in the first quarter 2004." Edison, N.J. firm incurred a net loss of $1.4 mil in the quarter, compared to a $548,000 deficit the prior year, due to lower private label sales and higher selling, general and administrative expenses, company says...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS096860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel